Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study - The Lancet Oncology
Race Review : Nike She Runs 2013 | My Running Addiction
Race Review : Nike She Runs 2013 | My Running Addiction
The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort | PLOS ONE
Race Review : Nike She Runs 2013 | My Running Addiction